Debarment

Debarment is a penalty set forth under the Food and Drugs Act,^[1] which the U.S. Food and Drug Administration can, and sometimes must, impose on persons or companies that engage in criminal conduct with respect to the development or approval of new drugs. The penalty itself is a prohibition against that person or company from submitting or assisting in the submission of such an application.

In the earliest debarment cases, following the passage of the laws permitting the imposition of this penalty, the penalty was imposed on persons who had committed the offending acts had done so prior to the passage of those laws. They therefore argued that the application of this penalty to them was an unconstitutional ex post facto application of the law. The courts rejected this argument, finding that debarment was not intended as a punishment, but rather as a means of protecting the public from persons who ad exhibited the capacity for engaging in such conduct.^[2]

Another constitutional issue raised was double jeopardy, it being argued that persons who had been tried, convicted, and sentenced to a particular punishment by a court of law could not be further penalized for the same offense. The courts also rejected this contention, again on the basis that debarment was intended to protect the public, rather than to punish the offender.